Development of isatin-thiazolo[3,2-a]benzimidazole hybrids as novel CDK2 inhibitors with potent in vitro apoptotic anti-proliferative activity: Synthesis, biological and molecular dynamics investigations.

Published on Feb 18, 2021in Bioorganic Chemistry5.275
· DOI :10.1016/J.BIOORG.2021.104748
Wagdy M. Eldehna26
Estimated H-index: 26
(Kafrelsheikh University),
Mahmoud A. El Hassab3
Estimated H-index: 3
+ 8 AuthorsRadwan El-Haggar7
Estimated H-index: 7
(Helwan University)
Source
Abstract
Abstract In the current medical era, human health is experiencing numerous challenges, particularly the human malignancies. Therefore, the therapeutic arsenal for these malignancies is to be inexorably enhanced with new treatments that target tumor cells in a selective manner. In this regard, the present work aims at developing a new set of small molecules featuring the privileged isatin scaffold conjugated with a thiazolo[3,2-a]benzimidazole (TBI) motif through a cleavable hydrazide linker (7a-e and 10a-i) as potential anticancer CDK2 inhibitors. The large tricyclic TBI motif is anticipated to achieve a plethora of hydrophobic interactions within the CDK2 binding site. The growth of the two examined cell lines was significantly inhibited by most the prepared hybrids with IC50 ranges; (2.60±1.47 – 20.90±1.17µM, against MDA-MB-231) and (1.27±0.06 – 16.83±0.95µM, against MCF-7). In particular, hybrids 7a, 7d and 10adisplayed potent dual activity against the examined cell lines, and thus selected for further investigations. They exerted a significance alteration in the cell cycle progression, in addition to an apoptosis induction within both MDA-MB-231 and MCF-7cells. Furthermore, 7a, 7d and 10a displayed potent CDK2 inhibitory action (IC50= 96.46±5.3, 26.24±1.4 and 42.95±2.3nM, respectively). The docking simulations unveiled, as expected, the ability of the TBI ring to well-accommodate and establish several hydrophobic interactions within a hydrophobic pocket in the CDK2 binding site. Also, the docking simulations highlighted the significance of incorporation of the hydrazide linker and isatin unsubstituted (NH) functionality in the H-bonding interactions. Interestingly, the most potent CDK2 inhibitor 7d achieved the best binding score (-11.2 Kcal/mole) and formed the most stable complex with CDK2 enzyme (RMSD = 1.24 A) in a 100 ns MD simulation. In addition, the MM-PBSA calculations ascribed the lowest binding free energy to the 7d–CDK2 complex (-323.69± 15.17 kj/mol). This could be attributed to an incorporation of the 5-OCH3 group that was engaged in an extra hydrogen bonding with key THR14 amino acid residue. Finally, these results suggested hybrid 7d as a good candidate for further optimization as promising breast cancer antitumor agent and CDK2 inhibitor.
📖 Papers frequently viewed together
2018
1 Author (Rui Gao)
2015
1 Author (Elena Costa)
References86
Newest
#2Eman Esmat El-Bastawissy (Tanta University)H-Index: 3
Last. Tarek F. El-Moselhy (Tanta University)H-Index: 7
view all 3 authors...
AbstractHCV NS5B polymerase has been one of the most attractive target for developing new drugs for HCV infection and many drugs were successfully developed, but all of them were designed for targe...
Source
Last. Radwan El-Haggar (Helwan University)H-Index: 7
view all 14 authors...
ABSTRACT Herein we describe design and synthesis of different series of novel small molecules featuring 3-methylthiazolo[3,2-a]benzimidazole moiety (as a tail) connected to the zinc anchoring benzenesulfonamide moiety via ureido (7), enaminone (12), hydrazone (14), or hydrazide (15) linkers. The newly prepared conjugates have been screened for their inhibitory activities toward four human (h) carbonic anhydrase (CA, EC 4.2.1.1) isoforms: hCA I, II, IX and XII. Thereafter, the urea and enaminone ...
Source
#1Ahmed SabtH-Index: 4
#2Wagdy M. Eldehna (Kafrelsheikh University)H-Index: 26
Last. Hatem A. Abdel-AzizH-Index: 36
view all 7 authors...
Human health in the current medical era is facing numerous challenges, especially cancer. So, the therapeutic arsenal for cancer should be unremittingly enriched with novel small molecules that sel...
Source
#1Tarfah Al-WarhiH-Index: 10
#2Mahmoud F. Abo-Ashour (Egyptian Russian University)H-Index: 10
Last. Hatem A. Abdel-AzizH-Index: 36
view all 10 authors...
As a continuation for our previous work, a novel set of N-alkylindole-isatin conjugates (7, 8a-c, 9 and 10a-e) is here designed and synthesised with the prime aim to develop more efficient isatin-based antitumor candidates. Utilising the SAR outputs from the previous study, our design here is based on appending four alkyl groups with different length (ethyl and n-propyl), bulkiness (iso-propyl) and unsaturation (allyl) on N-1 of indole motif, with subsequent conjugation with different N-unsubsti...
Source
#1Tarfah Al-Warhi (Princess Nora bint Abdul Rahman University)H-Index: 10
#2Ahmed M. El Kerdawy (Cairo University)H-Index: 14
Last. Ghada H. Al-AnsaryH-Index: 11
view all 8 authors...
On account of their overexpression in a wide range of human malignancies, cyclin-dependent kinases (CDKs) are among the most validated cancer targets, and their inhibition has been featured as a valuable strategy for anticancer drug discovery. In this study, a hybrid pharmacophore approach was adopted to develop two series of oxindole–indole conjugates (6a–i and 9a–f) and carbocycle–indole conjugates (11a,b) as efficient antitumor agents with potential inhibitory action toward CDK4. All oxindole...
Source
#1Wagdy M. Eldehna (Kafrelsheikh University)H-Index: 26
#2Ghada S. Hassan (Mansoura University)H-Index: 19
Last. Ghada H. Al-Ansary (Ain Shams University)H-Index: 11
view all 6 authors...
Diverse indoles and bis-indoles extracted from marine sources have been identified as promising anticancer leads. Herein, we designed and synthesized novel bis-indole series 7a–f and 9a–h as Topsentin and Nortopsentin analogs. Our design is based on replacing the heterocyclic spacer in the natural leads by a more flexible hydrazide linker while sparing the two peripheral indole rings. All the synthesized bis-indoles were examined for their antiproliferative action against human breast cancer (MC...
Source
#1Zhen DingH-Index: 1
#2Minfeng Zhou (Shaoxing University)H-Index: 1
Last. Cheng ZengH-Index: 1
view all 3 authors...
The isatin framework is a useful template for the development of novel anticancer agents. This is exemplified by the fact that several isatin-based anticancer agents, such as semaxanib, sunitinib, nintedanib, and hesperadin, are already in use or under clinical trials for the treatment of diverse kinds of cancers. Isatin-based hybrids could be obtained by incorporating other anticancer pharmacophores into the isatin skeleton and they have the potential to overcome drug resistance with reduced si...
Source
#1Rebecca L. Siegel (ACS: American Cancer Society)H-Index: 68
#2Kimberly D. Miller (ACS: American Cancer Society)H-Index: 29
Last. Ahmedin Jemal (ACS: American Cancer Society)H-Index: 139
view all 3 authors...
Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States and compiles the most recent data on population-based cancer occurrence. Incidence data (through 2016) were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries. Mortality data (through 2017) were collected by the National Center for Health Statis...
Source
#1Yani HouH-Index: 1
#2Congshan ShangH-Index: 1
Last. Jie YunH-Index: 1
view all 4 authors...
Isatin and azole moieties, which have the ability to form various noncovalent interactions with different therapeutic targets, are common pharmacophores in drug development. Isatin and azole derivatives possess promising in vitro and in vivo anticancer activity, and many of them, such as semaxanib, sunitinib, and carboxyamidotriazole, could be used to treat various cancers. Thus, it is conceivable that hybridization of the isatin moiety with azole may provide a valuable therapeutic intervention ...
Source
#1Hazem A. Mahdy (Al-Azhar University)H-Index: 11
#2Mohammed K. Ibrahim (Al-Azhar University)H-Index: 3
Last. Ibrahim H. Eissa (Al-Azhar University)H-Index: 23
view all 11 authors...
Abstract Inhibiting VEGFR-2 has been set up as a therapeutic strategy for treatment of cancer. Accordingly, new quinazoline-based derivatives having the structural features of VEGFR-2 inhibitors were designed and synthesized. Anti-proliferative activities were evaluated against three human cancer cell lines (HepG-2, MCF-7 and HCT-116) using MTT assay method. Doxorubicin and sorafenib were used as positive controls. Compounds 26b, 29a, 29b and 30 showed excellent anti-cancer activities against al...
Source
Cited By2
Newest
#1Reham F. BarghashH-Index: 9
#2Wagdy M. Eldehna (Kafrelsheikh University)H-Index: 26
Last. Hatem A. Abdel-AzizH-Index: 36
view all 6 authors...
Abstract null null In the current study, we report on the development of novel series of pyrazolo[3,4-b]pyridine derivatives (8a-u, 11a-n, and 14a,b) as potential anticancer agents. The prepared pyrazolo[3,4-b]pyridines have been screened for their antitumor activity in vitro at NCI-DTP. Thereafter, compound 8a was qualified by NCI for full panel five-dose assay to assess its GI50, TGI and LC50 values. Compound 8a showed broad-spectrum anti-proliferative activities over the whole NCI panel, with...
Source
#1Wagdy M. Eldehna (Kafrelsheikh University)H-Index: 26
#2Rofaida Salem (Kafrelsheikh University)H-Index: 1
Last. Hatem A. Abdel-AzizH-Index: 36
view all 11 authors...
In the current work, a new set of carbohydrazide linked benzofuran-isatin conjugates (5a-e and 7a-i) was designed and synthesised. The anticancer activity for compounds (5b-d, 7a, 7b, 7d and 7g) was measured against NCI-55 human cancer cell lines. Compound 5d was the most efficient, and thus subjected to the five-dose screen where it showed excellent broad activity against almost all tested cancer subpanels. Furthermore, all conjugates (5a-e and 7a-i) showed a good anti-proliferative activity to...
Source
Abstract null null Antibiotic resistance is rapidly evolving at an alarming rate, posing a severe threat to humanity. In an effort to develop compounds with antimicrobial activity, we synthesized a series of isatin-1,2,3-triazole hybrids 12–21 using the copper(I)-catalyzed azide-alkyne cycloaddition (CuAAC) reactions. Structural verification of the new isatin-1,2,3-triazole hybrids was accomplished using a variety of spectroscopic characterization techniques. The novel hybrids were evaluated for...
Source
#1Garvit Satija (Jamia Hamdard)
#2Barkha Sharma (Jamia Hamdard)
Last. Mohammad Mumtaz Alam (Jamia Hamdard)H-Index: 21
view all 9 authors...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.